|
BRTX Biorestorative Therapies Inc 1505497 |
| Income Statement |
|
Revenue
|
form10-q
|
233,600 |
|
Net Income
|
form10-q
|
-1,091,416 |
|
Profit Margin
|
|
-467.22% |
| Balance Sheet |
|
Current Assets
|
13,508,939 |
|
Assets
|
14,573,451 |
|
Current Liabilities
|
4,581,535 |
|
Liabilities
|
4,581,535 |
|
Equity
|
9,991,916 |
|
Shares Out
|
6,920,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-5,882,501 |
|
Investing Cash Flow
|
-1,018,078 |
| Market Analysis |
Market Cap
|
12,242,716 |
|
Price
|
1.64 |
|
BVPS
|
1.44 |
|
PB
|
1.14 |
|
EPS
|
-1.22 |
|
PS
|
13.10 |
|
FCF
|
-6,900,579 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BRTX documents filed with the SEC.
BRTX Filings
Clear
